753OFINAL OVERALL SURVIVAL (OS) ANALYSIS OF COU-AA-302, A RANDOMIZED PHASE 3 STUDY OF ABIRATERONE ACETATE (AA) IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) PATIENTS (PTS) WITHOUT PRIOR CHEMOTHERAPY.
暂无分享，去创建一个
F. Saad | K. Miller | C. Sternberg | D. Rathkopf | P. Mulders | K. Fizazi | C. Ryan | T. Griffin | P. De Porre | A. Molina | T. Kheoh | M. Smith | J. Li | V. Naini | Y. Park | Y. Park | Y. Park